hem 1 Search Results


rabbit polyclonal antibodies for hem1  (Novus Biologicals)
92
Novus Biologicals rabbit polyclonal antibodies for hem1
Rabbit Polyclonal Antibodies For Hem1, supplied by Novus Biologicals, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/rabbit polyclonal antibodies for hem1/product/Novus Biologicals
Average 92 stars, based on 1 article reviews
rabbit polyclonal antibodies for hem1 - by Bioz Stars, 2026-02
92/100 stars
  Buy from Supplier
hem1  (Novus Biologicals)
93
Novus Biologicals hem1
Hem1, supplied by Novus Biologicals, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/hem1/product/Novus Biologicals
Average 93 stars, based on 1 article reviews
hem1 - by Bioz Stars, 2026-02
93/100 stars
  Buy from Supplier
hem1∆ yeast strain  (SAS institute)
90
SAS institute hem1∆ yeast strain
Hem1∆ Yeast Strain, supplied by SAS institute, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/hem1∆ yeast strain/product/SAS institute
Average 90 stars, based on 1 article reviews
hem1∆ yeast strain - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier
antisense mo hem1  (Gene Tools Inc)
90
Gene Tools Inc antisense mo hem1
Morpholino targeting of Hemogen inhibits erythropoiesis in embryonic zebrafish. Embryos were injected with 2 to 4 ng <t>antisense</t> MO targeted to the first 25 coding nucleotides of Hemogen . (A-B) O -dianisidine staining of erythrocytes was decreased in morphants (MO) relative to wild-type embryos (WT) or embryos rescued with 500 pg synthetic Hemgn mRNA (zHem) at 24 hpf. (ANOVA, Tukey post hoc test, P <0.001). (C-E) Live wild-type (C), <t>Hem1</t> MO-injected (D) and Hem1 mm mismatch MO-injected (E) Tg(Lcr:EGFP) cz3325Tg embryos at 20 hpf. Morphants showed decreased EGFP expression in the ICM compared to the wild-type and mismatch MO controls. (F-H) Live wild-type (F), Hem1 MO-injected (G) and Hem1 mm MO-injected (H) embryos at 72 hpf. Morphant embryos have fewer EGFP+ cells in circulation compared to the two controls. The dorsal aortas of embryos (insets above F-H) were magnified 20× to permit quantitation of EGFP+ erythrocytes. Background red (D,G) and green (E,H) fluorescence was generated by the fluorescent labels on the MOs. (I) In vivo flow quantitation of EGFP+ erythrocyte concentrations between 3 and 6 dpf in Hem1-injected ( n =9,7,7,7), Hem1mm-injected ( n =13,14,11,11) and uninjected ( n =5,10,10,9) embryos. Data shown as means±s.e.m. (* P ≤0.05, ** P ≤0.001, ANOVA, Tukey-Kramer post hoc test). Arrowheads show notochord kinking. Scale bars: 500 µm (A-F); 100 µm (inset).
Antisense Mo Hem1, supplied by Gene Tools Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/antisense mo hem1/product/Gene Tools Inc
Average 90 stars, based on 1 article reviews
antisense mo hem1 - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier
hem1 ko strain nckap1ltm1.2.sixt  (Jackson Laboratory)
90
Jackson Laboratory hem1 ko strain nckap1ltm1.2.sixt
Morpholino targeting of Hemogen inhibits erythropoiesis in embryonic zebrafish. Embryos were injected with 2 to 4 ng <t>antisense</t> MO targeted to the first 25 coding nucleotides of Hemogen . (A-B) O -dianisidine staining of erythrocytes was decreased in morphants (MO) relative to wild-type embryos (WT) or embryos rescued with 500 pg synthetic Hemgn mRNA (zHem) at 24 hpf. (ANOVA, Tukey post hoc test, P <0.001). (C-E) Live wild-type (C), <t>Hem1</t> MO-injected (D) and Hem1 mm mismatch MO-injected (E) Tg(Lcr:EGFP) cz3325Tg embryos at 20 hpf. Morphants showed decreased EGFP expression in the ICM compared to the wild-type and mismatch MO controls. (F-H) Live wild-type (F), Hem1 MO-injected (G) and Hem1 mm MO-injected (H) embryos at 72 hpf. Morphant embryos have fewer EGFP+ cells in circulation compared to the two controls. The dorsal aortas of embryos (insets above F-H) were magnified 20× to permit quantitation of EGFP+ erythrocytes. Background red (D,G) and green (E,H) fluorescence was generated by the fluorescent labels on the MOs. (I) In vivo flow quantitation of EGFP+ erythrocyte concentrations between 3 and 6 dpf in Hem1-injected ( n =9,7,7,7), Hem1mm-injected ( n =13,14,11,11) and uninjected ( n =5,10,10,9) embryos. Data shown as means±s.e.m. (* P ≤0.05, ** P ≤0.001, ANOVA, Tukey-Kramer post hoc test). Arrowheads show notochord kinking. Scale bars: 500 µm (A-F); 100 µm (inset).
Hem1 Ko Strain Nckap1ltm1.2.Sixt, supplied by Jackson Laboratory, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/hem1 ko strain nckap1ltm1.2.sixt/product/Jackson Laboratory
Average 90 stars, based on 1 article reviews
hem1 ko strain nckap1ltm1.2.sixt - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier
c. glabrata hem1 sequence  (Pasteur Institute)
90
Pasteur Institute c. glabrata hem1 sequence
Morpholino targeting of Hemogen inhibits erythropoiesis in embryonic zebrafish. Embryos were injected with 2 to 4 ng <t>antisense</t> MO targeted to the first 25 coding nucleotides of Hemogen . (A-B) O -dianisidine staining of erythrocytes was decreased in morphants (MO) relative to wild-type embryos (WT) or embryos rescued with 500 pg synthetic Hemgn mRNA (zHem) at 24 hpf. (ANOVA, Tukey post hoc test, P <0.001). (C-E) Live wild-type (C), <t>Hem1</t> MO-injected (D) and Hem1 mm mismatch MO-injected (E) Tg(Lcr:EGFP) cz3325Tg embryos at 20 hpf. Morphants showed decreased EGFP expression in the ICM compared to the wild-type and mismatch MO controls. (F-H) Live wild-type (F), Hem1 MO-injected (G) and Hem1 mm MO-injected (H) embryos at 72 hpf. Morphant embryos have fewer EGFP+ cells in circulation compared to the two controls. The dorsal aortas of embryos (insets above F-H) were magnified 20× to permit quantitation of EGFP+ erythrocytes. Background red (D,G) and green (E,H) fluorescence was generated by the fluorescent labels on the MOs. (I) In vivo flow quantitation of EGFP+ erythrocyte concentrations between 3 and 6 dpf in Hem1-injected ( n =9,7,7,7), Hem1mm-injected ( n =13,14,11,11) and uninjected ( n =5,10,10,9) embryos. Data shown as means±s.e.m. (* P ≤0.05, ** P ≤0.001, ANOVA, Tukey-Kramer post hoc test). Arrowheads show notochord kinking. Scale bars: 500 µm (A-F); 100 µm (inset).
C. Glabrata Hem1 Sequence, supplied by Pasteur Institute, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/c. glabrata hem1 sequence/product/Pasteur Institute
Average 90 stars, based on 1 article reviews
c. glabrata hem1 sequence - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier
hem1 advanced monitor  (Edwards Lifesciences Inc)
90
Edwards Lifesciences Inc hem1 advanced monitor
Morpholino targeting of Hemogen inhibits erythropoiesis in embryonic zebrafish. Embryos were injected with 2 to 4 ng <t>antisense</t> MO targeted to the first 25 coding nucleotides of Hemogen . (A-B) O -dianisidine staining of erythrocytes was decreased in morphants (MO) relative to wild-type embryos (WT) or embryos rescued with 500 pg synthetic Hemgn mRNA (zHem) at 24 hpf. (ANOVA, Tukey post hoc test, P <0.001). (C-E) Live wild-type (C), <t>Hem1</t> MO-injected (D) and Hem1 mm mismatch MO-injected (E) Tg(Lcr:EGFP) cz3325Tg embryos at 20 hpf. Morphants showed decreased EGFP expression in the ICM compared to the wild-type and mismatch MO controls. (F-H) Live wild-type (F), Hem1 MO-injected (G) and Hem1 mm MO-injected (H) embryos at 72 hpf. Morphant embryos have fewer EGFP+ cells in circulation compared to the two controls. The dorsal aortas of embryos (insets above F-H) were magnified 20× to permit quantitation of EGFP+ erythrocytes. Background red (D,G) and green (E,H) fluorescence was generated by the fluorescent labels on the MOs. (I) In vivo flow quantitation of EGFP+ erythrocyte concentrations between 3 and 6 dpf in Hem1-injected ( n =9,7,7,7), Hem1mm-injected ( n =13,14,11,11) and uninjected ( n =5,10,10,9) embryos. Data shown as means±s.e.m. (* P ≤0.05, ** P ≤0.001, ANOVA, Tukey-Kramer post hoc test). Arrowheads show notochord kinking. Scale bars: 500 µm (A-F); 100 µm (inset).
Hem1 Advanced Monitor, supplied by Edwards Lifesciences Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/hem1 advanced monitor/product/Edwards Lifesciences Inc
Average 90 stars, based on 1 article reviews
hem1 advanced monitor - by Bioz Stars, 2026-02
90/100 stars
  Buy from Supplier

Image Search Results


Morpholino targeting of Hemogen inhibits erythropoiesis in embryonic zebrafish. Embryos were injected with 2 to 4 ng antisense MO targeted to the first 25 coding nucleotides of Hemogen . (A-B) O -dianisidine staining of erythrocytes was decreased in morphants (MO) relative to wild-type embryos (WT) or embryos rescued with 500 pg synthetic Hemgn mRNA (zHem) at 24 hpf. (ANOVA, Tukey post hoc test, P <0.001). (C-E) Live wild-type (C), Hem1 MO-injected (D) and Hem1 mm mismatch MO-injected (E) Tg(Lcr:EGFP) cz3325Tg embryos at 20 hpf. Morphants showed decreased EGFP expression in the ICM compared to the wild-type and mismatch MO controls. (F-H) Live wild-type (F), Hem1 MO-injected (G) and Hem1 mm MO-injected (H) embryos at 72 hpf. Morphant embryos have fewer EGFP+ cells in circulation compared to the two controls. The dorsal aortas of embryos (insets above F-H) were magnified 20× to permit quantitation of EGFP+ erythrocytes. Background red (D,G) and green (E,H) fluorescence was generated by the fluorescent labels on the MOs. (I) In vivo flow quantitation of EGFP+ erythrocyte concentrations between 3 and 6 dpf in Hem1-injected ( n =9,7,7,7), Hem1mm-injected ( n =13,14,11,11) and uninjected ( n =5,10,10,9) embryos. Data shown as means±s.e.m. (* P ≤0.05, ** P ≤0.001, ANOVA, Tukey-Kramer post hoc test). Arrowheads show notochord kinking. Scale bars: 500 µm (A-F); 100 µm (inset).

Journal: Biology Open

Article Title: Divergent Hemogen genes of teleosts and mammals share conserved roles in erythropoiesis: analysis using transgenic and mutant zebrafish

doi: 10.1242/bio.035576

Figure Lengend Snippet: Morpholino targeting of Hemogen inhibits erythropoiesis in embryonic zebrafish. Embryos were injected with 2 to 4 ng antisense MO targeted to the first 25 coding nucleotides of Hemogen . (A-B) O -dianisidine staining of erythrocytes was decreased in morphants (MO) relative to wild-type embryos (WT) or embryos rescued with 500 pg synthetic Hemgn mRNA (zHem) at 24 hpf. (ANOVA, Tukey post hoc test, P <0.001). (C-E) Live wild-type (C), Hem1 MO-injected (D) and Hem1 mm mismatch MO-injected (E) Tg(Lcr:EGFP) cz3325Tg embryos at 20 hpf. Morphants showed decreased EGFP expression in the ICM compared to the wild-type and mismatch MO controls. (F-H) Live wild-type (F), Hem1 MO-injected (G) and Hem1 mm MO-injected (H) embryos at 72 hpf. Morphant embryos have fewer EGFP+ cells in circulation compared to the two controls. The dorsal aortas of embryos (insets above F-H) were magnified 20× to permit quantitation of EGFP+ erythrocytes. Background red (D,G) and green (E,H) fluorescence was generated by the fluorescent labels on the MOs. (I) In vivo flow quantitation of EGFP+ erythrocyte concentrations between 3 and 6 dpf in Hem1-injected ( n =9,7,7,7), Hem1mm-injected ( n =13,14,11,11) and uninjected ( n =5,10,10,9) embryos. Data shown as means±s.e.m. (* P ≤0.05, ** P ≤0.001, ANOVA, Tukey-Kramer post hoc test). Arrowheads show notochord kinking. Scale bars: 500 µm (A-F); 100 µm (inset).

Article Snippet: The antisense MO Hem1 (5′-TCTCTTTCTCCAACGGGTCTTCCAT-3′), which targets the first 25 base pairs of the zebrafish Hemogen open reading frame, was designed according to the manufacturer's instructions (Gene Tools LLC, Philomath, USA).

Techniques: Injection, Staining, Expressing, Quantitation Assay, Fluorescence, Generated, In Vivo